Medicine Man Technologies Announces Appointment of Brian Ruden, Co-Founder and CEO of the Starbuds Chain of Dispensaries, to its Board of Directors

Medicine Man Technologies Inc. (OTCQX: MDCL) (the “Company”) announced the election of Brian Ruden to its Board of Directors. Ruden is the co-founder and CEO of the Starbuds chain of dispensaries and a recognized business leader in the cannabis community with extensive regulated cannabis knowledge and expertise.

“Brian joins our Board at the forefront of the Company’s next stage of growth,” said Justin Dye, Chief Executive Officer of Medicine Man Technologies. “As the co-founder and CEO of Starbuds, one of our announced pending acquisitions, Brian is an innovator in the cannabis industry and has demonstrated a successful track record in the national rollout and global expansion of its dispensaries. His experience as an entrepreneur, a lawyer, and a recognized leader will be invaluable to the Company, our employees, our customers and shareholders.”

Since 2010, Ruden has owned and operated cannabis businesses under the Starbuds brand. He has grown this brand into multi-state operations including ColoradoHawaiiLouisianaMarylandMassachusettsOklahomaWashington D.C., and international markets. Under his leadership, Starbuds has become one of the most recognized and successful retail cannabis operations in North America. In 2014, Ruden founded Starbuds Consulting, a consulting company which provides strategic advice to start-up cannabis operations. Ruden received his law degree from the University of DenverSturm College of Law, and before entering the cannabis industry, he was a tax attorney in Colorado.

“Medicine Man Technologies is a leader in the cannabis industry,” said Brian Ruden. “I am excited to bring my experience in creating and growing cannabis operations and look forward to working with the leadership team and the other pioneering entrepreneurs that are slated to join the Medicine Man Technologies team. My goal is to bring a focus on operational excellence, offer a depth and breadth of cannabis products that consumers will enjoy, and drive top and bottom-line growth during this critical time in the Company’s evolution.”

Mr. Ruden will serve along with the other four directors, Justin Dye, Executive Chairman and Chief Executive Officer of the Company, Andy Williams, Vice-Chair and President of the Company, Bob DeGabrielle Chief Operating Officer of the Company, and Leo Riera, partner at Dye Capital & Company.

For more information about Medicine Man Technologies, please visit https://www.MedicineManTechnologies.com/.

Related posts

GW Pharmaceuticals Receives Approval for 5 New Patents for Epidiolex

Editor

Stanley Brothers Holdings CBD Company Charlottes Web’s Parent Company to Go Public in Canada

Editor

Kenwood Investments Raises $26.4 Million For Sonoma Outdoor Lifestyle Club Expansion

CCT IMPACT Agent

Leave a Comment